About AUGMENT THERAPEUTICS INC.
Augment Therapeutics is an early-stage pharmaceutical R&D company focused on developing 'Enhanced' versions of off-patent drugs using proprietary linker/prodrug technologies. Their goal is to create safer and more effective medicines through the FDA's 505(b)(2) regulatory pathway.
Development of enhanced versions of existing generic drugs using novel linker/prodrug technologiesUtilization of FDA's 505(b)(2) regulatory pathway for drug development and approvalPreclinical and clinical research in pharmaceutical developmentRegulatory expertise in FDA submissions and drug approval processes
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AUGMENT THERAPEUTICS INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.